Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SEAGEN-INC-10808/news/Seagen-gibt-bekannt-dass-ADCETRIS-Brentuximab-vedotin-plus-neuartige-Immuntherapiekombination-b-44098684/?utm_source=whatsapp&utm_medium=social&utm_campaign=share